Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation
Xueliang Du, … , Ming-Hui Zou,, Michael Brownlee
Xueliang Du, … , Ming-Hui Zou,, Michael Brownlee
Published April 3, 2006
Citation Information: J Clin Invest. 2006;116(4):1071-1080. https://doi.org/10.1172/JCI23354.
View: Text | PDF
Research Article Cardiology

Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation

  • Text
  • PDF
Abstract

Insulin resistance markedly increases cardiovascular disease risk in people with normal glucose tolerance, even after adjustment for known risk factors such as LDL, triglycerides, HDL, and systolic blood pressure. In this report, we show that increased oxidation of FFAs in aortic endothelial cells without added insulin causes increased production of superoxide by the mitochondrial electron transport chain. FFA-induced overproduction of superoxide activated a variety of proinflammatory signals previously implicated in hyperglycemia-induced vascular damage and inactivated 2 important antiatherogenic enzymes, prostacyclin synthase and eNOS. In 2 nondiabetic rodent models — insulin-resistant, obese Zucker (fa/fa) rats and high-fat diet–induced insulin-resistant mice — inactivation of prostacyclin synthase and eNOS was prevented by inhibition of FFA release from adipose tissue; by inhibition of the rate-limiting enzyme for fatty acid oxidation in mitochondria, carnitine palmitoyltransferase I; and by reduction of superoxide levels. These studies identify what we believe to be a novel mechanism contributing to the accelerated atherogenesis and increased cardiovascular disease risk occurring in people with insulin resistance.

Authors

Xueliang Du, Diane Edelstein, Silvana Obici, Ninon Higham, Ming-Hui Zou,, Michael Brownlee

×

Figure 8

Effect of inhibitors of lipolysis, CPT-1, and ROS on arterial PGI2 inactivation in 2 animal models of insulin resistance.

Options: View larger image (or click on image) Download as PowerPoint
Effect of inhibitors of lipolysis, CPT-1, and ROS on arterial PGI2 inact...
(A) Effect of FFA-induced ROS production on PGI2 synthase activity in insulin-resistant fa/fa rat aortae. Enzyme activity was determined in lean controls (FA/fa), fa/fa rats, and fa/fa rats treated with the SOD mimetic MnTBAP, the antilipolytic agent NA, or the CPT-I inhibitor etomoxir. Each bar represents the mean plus SEM of 6 rats per group. *P < 0.01 compared with lean controls. (B) Effect of FFA-induced ROS production on PGI2 synthase activity in high-fat diet–induced insulin-resistant mouse aortae. Enzyme activity was determined in standard-diet controls, high-fat diet–induced insulin-resistant mice, and high-fat diet–induced insulin-resistant mice treated with the SOD mimetic MnTBAP, the antilipolytic agent NA, or the CPT-I inhibitor etomoxir. Each bar represents the mean plus SEM of 6 mice per group. *P < 0.01 compared with controls.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts